M-A | Association of SGLT2 inhibitors with cardiovascular outcomes and safety events.

Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine